Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Fosmetpantotenate

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Drug co-invented by Martin Shkreli fails, pressuring his former biotech
    Drug co-invented by Martin Shkreli fails, pressuring his former biotech

    23 Aug 2019

    // Andrew Dunn BIOPHARMADIVE

    https://www.biopharmadive.com/news/drug-co-invented-by-martin-shkreli-fails-pressuring-his-former-biotech/561488/

    Andrew Dunn BIOPHARMADIVE
    23 Aug 2019
    Share Share
    Retrophin’s fosmetpantotenate fails in Phase III trial for PKAN
    Retrophin’s fosmetpantotenate fails in Phase III trial for PKAN

    23 Aug 2019

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/retrophin-fosmetpantotenate-iii-fails/

    CLINICALTRIALSARENA
    23 Aug 2019
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.